Evidence map›Paper›PMID 39329010›Full record

ArticleJournal of surgical case reports2024

Drug-free remission of immune thrombocytopenic purpura following resection of perihilar cholangiocarcinoma: a case report.

Masayoshi Sakuma, Daigoro Takahashi, Keitaro Kamei, Yuichi Takayama, Takamasa Takahashi, Hiroki Aoyama, Takahiro Hosoi, Atsuyuki Maeda

Abstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Masayoshi SakumaDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.ORCID https://orcid.org/0009-0000-9435-8529
Daigoro TakahashiDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.
Keitaro KameiDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.
Yuichi TakayamaDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.
Takamasa TakahashiDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.
Hiroki AoyamaDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.
Takahiro HosoiDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.
Atsuyuki MaedaDepartment of Surgery, Ogaki Municipal Hospital, 4-86, Minaminokawa-cho, Ogaki city, Gifu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder. Although secondary ITP, caused by various underlying diseases, including some malignant tumors, has been reported, instances of ITP resolving after successful treatment of the underlying cause are uncommon and noteworthy. Herein, we present a case of a patient with perihilar cholangiocarcinoma (pCCA) and ITP who achieved drug-free remission of ITP following tumor resection. A 76-year-old man presented with pCCA complicated by ITP. Prednisolone treatment successfully managed his thrombocytopenia, allowing for a left hepatopancreatoduodenectomy. ITP relapse did not occur after discontinuation of prednisolone postoperatively. This case suggests that surgical resection of the underlying malignancy may induce remission of secondary ITP associated with pCCA.

Indexed as

hepatopancreatoduodenectomyimmune thrombocytopenic purpuraperihilar cholangiocarcinoma

Identifiers

PMID39329010
PMCPMC11427118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.